Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2007 Sep 13;584(Pt 3):963–981. doi: 10.1113/jphysiol.2007.137331

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2007 The Authors. Journal compilation © 2007 The Physiological Society

PMC Copyright notice

Metabolite kinetics A and B, glycerol Ra in men (A) and women (B). C and D, FA Ra in men (C) and women (D). E and F, ratio of glycerol Ra to FA Ra in men (E) and women (F). Values are means ±s.e.m. Men, n = 10; women, n = 8. Time (min), duration elapsed since beginning tracer infusion. Ra, rate of appearance. FFM, fat free mass. *45%trial significantly different from corresponding time points in Control trial, P < 0.05. #65%trial significantly different from corresponding time points in Control trial, P < 0.05. §45%trial significantly different from corresponding time points in 65%trial, P < 0.05. †Average postexercise (30 min to 180 min postexercise) in 45%trial significantly different from corresponding average in Control trial, P < 0.05. ‡Average postexercise (30 min to 180 min postexercise) in 65%trial significantly different from corresponding average in Control trial, P < 0.05.

Inline graphic — Metabolite kinetics A and B, glycerol Ra in men (A) and women (B). C and D, FA Ra in men (C) and women (D). E and F, ratio of glycerol Ra to FA Ra in men (E) and women (F). Values are means ±s.e.m. Men, n = 10; women, n = 8. Time (min), duration elapsed since beginning tracer infusion. Ra, rate of appearance. FFM, fat free mass. *45%trial significantly different from corresponding time points in Control trial, P < 0.05. #65%trial significantly different from corresponding time points in Control trial, P < 0.05. §45%trial significantly different from corresponding time points in 65%trial, P < 0.05. †Average postexercise (30 min to 180 min postexercise) in 45%trial significantly different from corresponding average in Control trial, P < 0.05. ‡Average postexercise (30 min to 180 min postexercise) in 65%trial significantly different from corresponding average in Control trial, P < 0.05.